BAYER Aspirin Extra Strength

CHEBI:CHEBI_750756

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
211887
pharm_class
Decreased Platelet Aggregation [PE]
route
ORAL
dosage_form
TABLET
listing_expiration_date
20241231
nui
N0000008832
pharm_class_epc
Platelet Aggregation Inhibitor [EPC]
pharm_class_moa
Cyclooxygenase Inhibitors [MoA]
pharm_class_cs
Anti-Inflammatory Agents, Non-Steroidal [CS]
active_ingredient_strength
500 mg/1
pharm_class_pe
Decreased Platelet Aggregation [PE]
product_type
HUMAN OTC DRUG
marketing_category
OTC MONOGRAPH DRUG
application_number
M013
active_ingredient_name
ASPIRIN
unii
R16CO5Y76E
labeler_name
Bayer HealthCare LLC.
manufacturer_name
Bayer HealthCare LLC.
marketing_start_date
20141223
package_marketing_start_date
20141223
generic_name
BAYER Aspirin Extra Strength
brand_name
BAYER Aspirin Extra Strength Caplets
brand_name_base
BAYER Aspirin
brand_name_suffix
Extra Strength Caplets
product_ndc
0280-2020
spl_id
0b618633-736e-6799-e063-6294a90a04f1
package_ndc
0280-2020-10
package_description
1 BOTTLE, PLASTIC in 1 CARTON (0280-2020-10) / 100 TABLET in 1 BOTTLE, PLASTIC
spl_set_id
0ae64cdb-4ea0-23af-e054-00144ff88e88
upc
0312843555075
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class